Advanced search×

World Kidney Day 2011: protect your kidneys, save your heart.

William G Couser, Miguel C Riella, and Joint International Society of Nephrology and International Federation of Kidney Foundations World Kidney Day 2011 Steering Committee

Med J Aust 194(5):225-7 (2011) PMID 21381992

Version: za2963e q8za8 q8zb6 q8zca q8zd9 q8ze2 q8zfe q8zg7
Buy PDF

Similar articles you may find interesting…

  1. Protective effect of CV247 against cisplatin nephrotoxicity in rats.
    C Máthé, G Szénási, and M Albert

    Hum Exp Toxicol (2013) PMID 23653282

    We hypothesized that the antioxidant and cyclooxygenase-2 (COX-2; prostaglandin-endoperoxide synthase 2) inhibitory components of CV can protect the kidneys from CDPP nephrotoxicity in rats. CDPP (6.5 mg/kg, intraperitoneally) slightly elevated serum creatinine (Crea) and blood urea nitrogen (BUN)...
    Buy PDF
  2. Reciprocal regulation of calcium-/phosphate-regulating hormones in cyclists during the Giro d'Italia 3-week stage race.
    G Lombardi, R Corsetti, and G Banfi

    Scand J Med Sci Sports (2013) PMID 23647316

    We studied nine cyclists during the 2011 Giro d'Italia stage race. Pre-analytical and analytical phases followed academic and anti-doping recommendations. Serum parathyroid hormone (PTH), 25(OH)D, total calcium, inorganic phosphorus, and plasma FGF23 were measured on days -1, 12, and 22 and correcte...
    Buy PDF
  3. Survival rate of anti-TNF alpha treatments for psoriasis in routine dermatological practice: a multicenter observational study.
    M Esposito, P Gisondi, and G Girolomoni

    Br J Dermatol (2013) PMID 23647206

    Adherence is an overall marker of treatment success, and it depends on multiple factors including efficacy and safety. Despite the large use of TNF alpha blockers in the treatment of plaque-type psoriasis, only few data regarding treatment adherence in routine clinical practice are available. OBJECT...
    Buy PDF